You might like
🌟 Not all nails need the same 🔨 at the same ⏰: we must thoughtfully leverage our oncologic armamentarium for each pt 🙏 Thanks @lukevitzthum & Dr. Pollom (@StanfordRadOnc) for great @IJROBP #gyzone case & @DrBezjakRO for mentorship & collab! Vote 👉 redjournal.org/poll
This figure shows the risk of bleeding by location and VEGFi status. Caveats are that this was delivered with highly conformal SABR and motion management. Still unclear what the optimal RT regimen is for ultracentral or if there is a safe washout period after VEGFi
A new study in the JTO from the Thoracic Rad Onc team demonstrates evidence of combined toxicity in patients receiving SABR and VEGF inhibitors. Toxicity is predominately observed in patients with ultra-central tumors. Link to study: authors.elsevier.com/a/1h41T_ZOPrsI…
@brianna_lau killing it at #WCLC2022 presenting secondary analysis of @StanfordRadOnc iSABR trial
We are pleased to announce that Quynh-Thu Le, MD, @Qle_stanford, will serve as one of our Group Chairs effective July 1, 2021. She joins Drs. Robert Mannel & Norman Wolmark as the NRG Oncology Group Chairs & principal investigators. Read more: ow.ly/zvDT50FjUe7
The moon perfectly aligned with @Scripps_Ocean Pier this morning 🌕 Photo by Erik Jepsen
And another shoutout to @DominicComtois for creating the essential R library *summarytools* view(dfSummary([your data frame])) Same warning applies
![MaartenvSmeden's tweet image. And another shoutout to @DominicComtois for creating the essential R library *summarytools*
view(dfSummary([your data frame]))
Same warning applies](https://pbs.twimg.com/media/EuwO6p_WgAEiaFm.jpg)
This morning I had a P2P with @evicorehc to discuss a treatment that is supported by NCCN guidelines. The consulting MD never called and now we have to find a new time that works for them. Its frustrating to have so many barriers to advocate for your patient.
A new study in the JTO from the Thoracic Rad Onc team demonstrates evidence of combined toxicity in patients receiving SABR and VEGF inhibitors. Toxicity is predominately observed in patients with ultra-central tumors. Link to study: authors.elsevier.com/a/1h41T_ZOPrsI…
#WCLC20 Updated data from KEYNOTE 799 presented by @MartinReck2 - pembrolizumab + chemoradiation in unresectable locally advanced stage III NSCLC. #LCSM @IASLC @OncoAlert
New guidelines for vaccinating individuals with #Cancer with #COVID19 vaccines released by @NCCN ✴️Vaccine is recommended for all pts on active therapy ✴️Delay vaccine ~3 months following transplant/ CAR-T therapy ✴️Immunize household members bit.ly/3bZqrCF
An interesting new method to diagnose and potentially account for residual confounding using competing events out the @drlorenmell lab.
While this awaiting #peerreview thought I’d put this out there for #Epidemiology and #Biostatistics researchers: #BRACE method to help reduce bias in #Database / CER studies: medrxiv.org/content/10.110…
Excited to join the team!
Excited to share the expansion of the @StanfordRadOnc Thoracic Radiation Oncology clinical service, to match the growth of the @StanfordCancer Thoracic Oncology program! Looking forward to pioneering more #RadOnc advances for our patients with #LungCancer #LCSM
Please join us in welcoming Dr. Minh Huynh-Le as a new assistant professor of radiology in GW Radiation Oncology! We are excited to have her join the #GWCancer family. Welcome, Dr. Huynh-Le! bit.ly/35VbKgG @MHuynhLe
Dr Le Péchoux @GustaveRoussy reports Lung ART trial #ESMO20. Post op 3D conformal #radiotherapy (54Gy) in pN2 NSCLC ⬇️mediast relapse BUT does not improve DFS AND ⬆️G3/4 acute & late cardiopulm toxicity Disappointing for #radonc but major trial for #lcsm community.
Everyone depends on the USPS. Seniors for their Social Security, veterans for their prescriptions, small businesses trying to keep their doors open. They can't be collateral damage for an administration more concerned with suppressing the vote than suppressing a virus.
Great work Abhishek! I'm excited to see what you will do at @DukeRadOnc
Trying for the 1st time to tweet my research, so here it goes...*deep breath* Virtual #ASCO20 poster evaluating the cost-effectiveness of #SABR in oligometastatic cancer using SABR-COMET published data. TL;DR SABR very cost-effective under wide range of assumptions. @UCSDRadMed
I was ‘catfished’ today. And by that I mean an unknown number from my hometown area code sent me a picture of a giant catfish they caught.
UMN medical school suspended classes UMN med students organize & take care of health providers kids so the Health care providers continue to work & not worry about their kids This is what we can do This is who we can be W/caring, compassion, & courage. This is the path through
Great job @UCSDRadMed residents with project design, fun annual #parkcity research retreat tradition. Missed Dr Murphy tho. Hope next year is biggest one yet!@lukevitzthum carry the torch!
United States Trends
- 1. #River 5,490 posts
- 2. Jokic 26.9K posts
- 3. Lakers 52.5K posts
- 4. #AEWDynamite 51K posts
- 5. Nemec 3,455 posts
- 6. #ReasonableDoubtHulu N/A
- 7. Clippers 14.9K posts
- 8. Shai 16.5K posts
- 9. joon 10.2K posts
- 10. Thunder 40.2K posts
- 11. #NIKKE3rdAnnivBattleReport 9,720 posts
- 12. Rejoice in the Lord 1,047 posts
- 13. #dispatch 82.3K posts
- 14. Ty Lue 1,230 posts
- 15. Mikey 71.2K posts
- 16. Markstrom 1,296 posts
- 17. Rory 8,197 posts
- 18. Steph 30.9K posts
- 19. Valve 60.6K posts
- 20. Joker 26.8K posts
You might like
-
Kiran A. Kumar, MD, MBA
@kakumar86 -
Dr. Loren K. Mell
@drlorenmell -
Anthony Paravati, MD, MBA
@DrAntoParavati -
Mark V. Mishra
@MarkMishraMD -
Eli Scher
@EliDScher -
Hyunsoo Joshua No, MD, CMD
@DoctorNoMD -
WesTalcottMD
@TalcottMd -
Stephanie Yoon
@yoonie_verse -
Bismarck Odei MD
@BismarckOdeiMD -
Laura Dover
@LauraDoverMD -
Douglas Holt
@DouglasHoltMD -
Christian Fernandez Olortegui
@ChrisFernOlor
Something went wrong.
Something went wrong.